The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
May 16th 2025
Aficamten, a cardiac myosin inhibitor, gains FDA approval, offering hope for improved cardiovascular health in patients with obstructive hypertrophic cardiomyopathy.
Daily Medication Pearl: Fondaparinux Sodium (Arixtra)
July 29th 2022Fondaparinux sodium (Arixtra) is indicated for prophylaxis of deep vein thrombosis (DVT) in patients undergoing hip fracture surgery (including extended prophylaxis), hip replacement surgery, knee replacement surgery, or abdominal surgery.
Read More
COVID-19 Vaccination Has No Impact on Placental Health, Suggesting Safety for Pregnant Women
July 28th 2022No differences were found among placenta health indictors, birth weights, or well-being scores between vaccinated and unvaccinated pregnant women, indicating that COVID-19 vaccination is safe for use in pregnant women.
Read More